From Lab to Litigation: Liability Risks in Medical Device and Pharmaceutical Product Development
Behind every medicine, medical device or other therapeutic goods on the market is years of research, testing and problem‑solving – not to mention a healthy amount of red tape. And with more than 2,900 organisations operating in the Life Sciences industry in Australia, brokers are seeing more clients working in this space – from biotech start‑ups to established pharmaceutical companies and medical device developers – each at different stages of the Life Sciences life cycle.
But understanding what these clients actually do and the risks they face at each stage can be challenging. Is their product considered a medical device? Do they need to be approved by a regulator? Who even regulates them? And what happens when a product moves from the lab bench into clinical trials or post‑market monitoring?
In our upcoming webinar, Nicole Carey and Steve Taylor break down the Life Sciences life cycle in a way that’s practical, engaging and tailored for brokers. They’ll provide a detailed step-by-step of how therapeutic goods are developed, tested and approved and how the exposures evolve along the way. More importantly, they’ll explain how a Life Sciences policy responds at each stage, giving brokers the confidence to guide clients through this complex landscape.
Whether you’re new to Life Sciences or already fielding enquiries from biotech and medical device clients, this session will help make the puzzle pieces click into place.
Benefits of attending this webinar
- Gain a clear understanding of the Life Sciences industry and the life cycle of medical products, from development through to post‑market use
- Identify key liability exposures that can arise at each stage of the product life cycle
- Build a deeper understanding of how Life Sciences insurance policies respond to these exposures and protect insureds
- Strengthen your ability to confidently advise clients operating within the Life Sciences sector
Webinar: From Lab to Litigation: Liability Risks in Medical Device and Pharmaceutical Product Development
Date: Wednesday, 15 April 2026 at 11.00 AM AEST
Registrations: Click here to register and be part of the session
Share this post on
From Lab to Litigation: Liability Risks in Medical Device and Pharmaceutical Product Development
AI in Hiring: Bias, Discrimination Risks and Merging Liability Considerations
Introducing bindIT Multi Quick Quote for eligible, straightforward risks